Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Other Income (Expense)

v3.8.0.1
Note 9 - Other Income (Expense)
9 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Other Income and Other Expense Disclosure [Text Block]
Note
9.
Other Income / (Expense):
 
The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows: 
 
   
Quarter Ended
   
Nine
Months
 
   
March 31,
   
March 31,
 
   
2018
   
2017
   
2018
   
2017
 
Interest expense
  $
(2,560
)
  $
(2,108
)
  $
(7,135
)
  $
(5,430
)
Interest income
   
162
     
73
     
307
     
211
 
Impairment of investment
   
(16,246
)
   
-
     
(16,246
)
   
-
 
Other non-operating income (expense), net
   
542
     
(326
)
   
(507
)
   
(1,206
)
Total other income (expense)
  $
(18,102
)
  $
(2,361
)
  $
(23,581
)
  $
(6,425
)
 
During the
third
quarter of fiscal
2018,
the Company recognized a
$16.2
million impairment on the write-down of its investment in Astute Medical, Inc. This loss is included in other income (expense) on the condensed consolidated Statement of Earnings and Comprehensive Income.